AMAG

AMAG Pharmaceuticals, Inc. News Headlines

$17.61
*  
0.09
 negative 
0.51%
Get AMAG Alerts
*Delayed - data as of Apr. 16, 2014 12:04 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AMAG Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Anacor, Valeant Settle Disputes - Analyst Blog
10/29/2013 5:20:01 PM - Zacks.com

Actavis Q3 Earnings Grow, Guides Up - Analyst Blog
10/29/2013 1:48:01 PM - Zacks.com

Narrower Q3 Loss at AMAG - Analyst Blog
10/24/2013 10:00:01 AM - Zacks.com

Illumina Tops Earnings, Ups Guidance - Analyst Blog
10/22/2013 3:01:01 PM - Zacks.com

Alimera Down on 3rd Iluvien CRL - Analyst Blog
10/21/2013 6:07:13 PM - Zacks.com

Anacor Shares Rise on Favorable Arbitration - Analyst Blog
10/21/2013 4:49:01 PM - Zacks.com

Zacks #1 Rank Additions for Monday - Tale of the Tape
10/21/2013 9:07:23 AM - Zacks.com

Positive Data on Omeros' OMS824 - Analyst Blog
10/18/2013 6:00:01 PM - Zacks.com

FDA Approves Novo Nordisk's NovoEight - Analyst Blog
10/18/2013 5:07:25 PM - Zacks.com

Strength Seen in Alkermes (ALKS): Stock Up 8.5% - Analyst Blog
10/18/2013 9:00:01 AM - Zacks.com

FDA Delays Verdict for AMAG's Feraheme - Analyst Blog
10/17/2013 5:00:01 PM - Zacks.com

Actelion Beats on Earnings and Revenues in Q3 - Analyst Blog
10/17/2013 12:07:03 PM - Zacks.com

Another Milestone for Isis Pharma - Analyst Blog
10/17/2013 11:07:12 AM - Zacks.com

Good News for Catalyst Pharma's Pipeline - Analyst Blog
10/16/2013 5:27:01 PM - Zacks.com

Insmed's Arikace Makes Progress - Analyst Blog
10/16/2013 4:46:44 PM - Zacks.com

Zacks #1 Rank Additions for Wednesday - Tale of the Tape
10/16/2013 9:30:01 AM - Zacks.com

AMAG Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape
10/16/2013 5:42:01 AM - Zacks.com

Encouraging Data on Protalix Candidate - Analyst Blog
10/15/2013 5:50:01 PM - Zacks.com

AMAG Shares Skid on FDA Notification - Analyst Blog
9/26/2013 4:33:45 PM - Zacks.com

Affymax: Putting The Pieces Together
8/24/2013 4:30:00 AM - Seeking Alpha

New Patent Issued for AMAG's Feraheme - Analyst Blog
8/9/2013 4:35:20 PM - Zacks.com

Astellas, FibroGen Start Phase II Study - Analyst Blog
8/6/2013 4:40:35 PM - Zacks.com

Narrower-Than-Expected Loss at AMAG - Analyst Blog
8/2/2013 4:07:25 PM - Zacks.com

Keryx Biopharmaceuticals Presents An Attractive Investment Opportunity
7/24/2013 10:28:00 AM - Seeking Alpha

FDA Decisions: Interesting Biotechnology Catalyst Events
7/9/2013 11:04:00 AM - Seeking Alpha